DHRDanaher Board Expands to 13 Members
Danaher (DHR) adds two directors, expanding its board to 13; director Spoon to retire in 2027. Governance implications amid recent acquisitions and leadership changes.
DANAHER CORP /DE/
DHRDHR: Founders Waive August 2026 RSUs
Danaher (DHR) founders Steven and Mitchell Rales waive rights to August 2026 RSUs. Key implications for investors on 2026-10-13.
DANAHER CORP /DE/
DHRDanaher CEO Transition: Julie Montgomery Named
Danaher (DHR) names Julie Montgomery CEO and grants executive equity awards. Key financials, segment mix, and investor implications on 2026-08-03.
DANAHER CORP /DE/
DHRDanaher Issues CHF 2.8B Senior Notes
Danaher (DHR) raises CHF 2.8B via seven-series senior notes on 2026-06-03. Key implications for debt profile, capital strategy and investor considerations.
DANAHER CORP /DE/
DHRDanaher to Acquire Masimo for $9.9B
Danaher (DHR) agrees to buy Masimo in a $9.9B cash deal, expanding its diagnostics business; strategic context, financials, and risks for investors.
DANAHER CORP /DE/
DHRDanaher CEO John Schwieters to Step Down
Danaher (DHR) says CEO John T. Schwieters will leave the company's board at the 2026 AGM, reducing board size. Key investor implications and context.
DANAHER CORP /DE/
DHRDanaher (DHR) Approves 35M Share Buyback
Danaher (DHR) board authorizes 35 million-share repurchase (≈4.9% of outstanding). Read financial context, balance sheet and shareholder-return analysis.
DANAHER CORP /DE/
DHRDanaher Revises Shareholder Rights Rules (DHR)
Danaher (DHR) updates procedures for shareholder proposals and nominations, altering submission and nomination processes per company disclosure.
DANAHER CORP /DE/